How Are Facebook Inc(NASDAQ:FB), Omeros Corporation(NASDAQ:OMER), and ESB Financial Corporation(NASDAQ:ESBF) Faring?
New York, NY – GDP INSIDER – 10/31/2014.
This article discusses three companies: Facebook Inc(NASDAQ:FB), Omeros Corporation(NASDAQ:OMER), and ESB Financial Corporation(NASDAQ:ESBF)
Facebook Inc(NASDAQ:FB) reported its third quarter financial results on Oct. 28th, 2014. The numbers included a daily active users figure of 864 million, a 19% year-over-year increase. More than any other figure in Facebook’s results report, this number suggests that the company’s revenue could grow due to an increase in paid advertising exposure for other companies. Additionally, Facebook also reported a mobile daily active users figure of 703 million, a 39% increase from the same period during the previous fiscal year.
Omeros Corporation(NASDAQ:OMER)is a Washington-based clinical-stage biopharmaceutical company that develops and commercializes products that target inflammation and disorders of the central nervous system. Yesterday, the company announced it had received the transitional pass-through status for Omirdria, which is the only FDA-approved product for intraocular administration. Omeros Corporation, which has a market capitalization of over $385 million and 34 million tradeable shares, has traded within a range of $6.92 to $18.80 over the past 52 weeks.
ESB Financial Corporation(NASDAQ:ESBF) is currently under investigation from Levi & Korsinsky and other law firms for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the company to WesBanco. The terms of the deal would send 0.502 shares of WesBanco stock and $1.76 in cash for each ESB Financial Corporation share. ESB Financial finished yesterday’s trading at a closing price of $18.59, while WesBanco closed at a price of $34.19.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.